# Open Label Treatment With tDCS for Parkinson's and Related Disorders for Improvement of Speech, Gait and Mood

> **NCT02104401** · PHASE1 · COMPLETED · sponsor: **Georgetown University** · enrollment: 10 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DEVICE:** tDCS

## Key facts

- **NCT ID:** NCT02104401
- **Lead sponsor:** Georgetown University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2014-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02104401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02104401, "Open Label Treatment With tDCS for Parkinson's and Related Disorders for Improvement of Speech, Gait and Mood". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02104401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*